Alpine Woods Capital Investors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Alpine Woods Capital Investors’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-2,800	Closed	-$318K	–	447
2014 Q3	$318K	Sell	2,800 -2,000	-42%	-$237K	0.02%	381
2014 Q2	$575	Hold	4,800	–	–	0.01%	309
2014 Q1	$615K	Sell	4,800 -1,000	-17%	-$128K	0.03%	278
2013 Q4	$716K	Sell	5,800 -1,000	-15%	-$122K	0.04%	244
2013 Q3	$799K	Hold	6,800	–	–	0.05%	218
2013 Q2	$763K	Buy	+6,800	New	+$798K	0.05%	210

Other funds holding BIO

ACM

Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Alpine Woods Capital Investors's BIO Position: Q4 2014 in Review

Alpine Woods Capital Investors sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2014, closing a stake of 2,800 shares — an estimated $318K sold.

Alpine Woods Capital Investors first reported a position in BIO in Q2 2013 and held it in 6 quarters. The position peaked at $799K in Q3 2013. 216 funds tracked by Wall St. Rank hold BIO as of Q4 2014.

Alpine Woods Capital Investors reported no remaining Bio-Rad Laboratories Class A position as of Q4 2014 after selling out during the quarter.
Alpine Woods Capital Investors sold 2,800 Bio-Rad Laboratories Class A shares in Q4 2014, an estimated $318K.
Alpine Woods Capital Investors first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 6 quarters.
Alpine Woods Capital Investors's Bio-Rad Laboratories Class A position peaked at $799K in Q3 2013.
216 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2014.

Based on Alpine Woods Capital Investors's 13F filing for Q4 2014, filed 10 Feb 2015.